Royce & Associates’s Monro MNRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-23,584
| Closed | -$378K | – | 807 |
|
|
2026
Q1 | $378K | Buy |
23,584
+773
| +3% | +$15K | ﹤0.01% | 725 |
|
|
2025
Q4 | $457K | Sell |
22,811
-3,826
| -14% | -$70.4K | ﹤0.01% | 715 |
|
|
2025
Q3 | $479K | Buy |
26,637
+8,578
| +47% | +$141K | ﹤0.01% | 711 |
|
|
2025
Q2 | $269K | Sell |
18,059
-8,098
| -31% | -$117K | ﹤0.01% | 746 |
|
|
2025
Q1 | $378K | Sell |
26,157
-12,246
| -32% | -$234K | ﹤0.01% | 748 |
|
|
2024
Q4 | $952K | Sell |
38,403
-3,353
| -8% | -$91.9K | 0.01% | 729 |
|
|
2024
Q3 | $1.21M | Sell |
41,756
-9,989
| -19% | -$258K | 0.01% | 703 |
|
|
2024
Q2 | $1.23M | Buy |
51,745
+13,129
| +34% | +$350K | 0.01% | 690 |
|
|
2024
Q1 | $1.22M | Buy |
38,616
+16,961
| +78% | +$524K | 0.01% | 703 |
|
|
2023
Q4 | $635K | Buy |
+21,655
| New | +$609K | 0.01% | 777 |
|
|
2020
Q3 | – | Sell |
-92,639
| Closed | -$5.09M | – | 1101 |
|
|
2020
Q2 | $5.09M | Sell |
92,639
-26,539
| -22% | -$1.41M | 0.06% | 456 |
|
|
2020
Q1 | $5.22M | Buy |
119,178
+4,200
| +4% | +$255K | 0.07% | 367 |
|
|
2019
Q4 | $8.99M | Sell |
114,978
-1,561
| -1% | -$118K | 0.08% | 349 |
|
|
2019
Q3 | $9.21M | Sell |
116,539
-56,279
| -33% | -$4.51M | 0.09% | 332 |
|
|
2019
Q2 | $14.7M | Sell |
172,818
-260,062
| -60% | -$21.7M | 0.13% | 209 |
|
|
2019
Q1 | $37.5M | Sell |
432,880
-2,833
| -0.7% | -$214K | 0.32% | 71 |
|
|
2018
Q4 | $30M | Buy |
435,713
+37,830
| +10% | +$2.76M | 0.27% | 84 |
|
|
2018
Q3 | $27.7M | Sell |
397,883
-19,943
| -5% | -$1.36M | 0.19% | 132 |
|
|
2018
Q2 | $24.3M | Buy |
417,826
+178,860
| +75% | +$10.1M | 0.17% | 164 |
|
|
2018
Q1 | $12.8M | Buy |
238,966
+10,740
| +5% | +$596K | 0.09% | 317 |
|
|
2017
Q4 | $13M | Sell |
228,226
-102,502
| -31% | -$5.34M | 0.09% | 329 |
|
|
2017
Q3 | $18.5M | Sell |
330,728
-9,522
| -3% | -$447K | 0.12% | 241 |
|
|
2017
Q2 | $14.2M | Sell |
340,250
-444,146
| -57% | -$22.1M | 0.09% | 300 |
|
|
2017
Q1 | $40.9M | Buy |
784,396
+20,175
| +3% | +$1.14M | 0.27% | 98 |
|
|
2016
Q4 | $43.7M | Sell |
764,221
-38,419
| -5% | -$2.21M | 0.28% | 100 |
|
|
2016
Q3 | $49.1M | Buy |
802,640
+113,640
| +16% | +$6.89M | 0.32% | 79 |
|
|
2016
Q2 | $43.8M | Sell |
689,000
-72,000
| -9% | -$4.76M | 0.29% | 87 |
|
|
2016
Q1 | $54.4M | Buy |
761,000
+10,000
| +1% | +$662K | 0.34% | 68 |
|
|
2015
Q4 | $49.7M | Hold |
751,000
| – | – | 0.3% | 87 |
|
|
2015
Q3 | $50.7M | Sell |
751,000
-36,300
| -5% | -$2.32M | 0.27% | 102 |
|
|
2015
Q2 | $48.9M | Sell |
787,300
-90,400
| -10% | -$5.64M | 0.21% | 128 |
|
|
2015
Q1 | $57.1M | Sell |
877,700
-51,740
| -6% | -$3.17M | 0.22% | 122 |
|
|
2014
Q4 | $53.7M | Sell |
929,440
-18,360
| -2% | -$978K | 0.19% | 141 |
|
|
2014
Q3 | $46M | Hold |
947,800
| – | – | 0.16% | 163 |
|
|
2014
Q2 | $50.4M | Buy |
947,800
+25,000
| +3% | +$1.37M | 0.15% | 169 |
|
|
2014
Q1 | $52.5M | Buy |
922,800
+24,000
| +3% | +$1.37M | 0.16% | 165 |
|
|
2013
Q4 | $50.7M | Buy |
898,800
+1,200
| +0.1% | +$59.2K | 0.15% | 175 |
|
|
2013
Q3 | $41.7M | Buy |
897,600
+13,200
| +1% | +$602K | 0.12% | 214 |
|
|
2013
Q2 | $42.5M | Buy |
+884,400
| New | +$38.9M | 0.13% | 209 |
|
Other funds holding MNRO
IC
GI
ECM
Royce & Associates's MNRO Position: Q2 2026 in Review
Royce & Associates sold out of Monro (MNRO) in Q2 2026, closing a stake of 23,584 shares — an estimated $378K sold.
Royce & Associates first reported a position in MNRO in Q2 2013 and held it in 39 quarters. The position peaked at $57.1M in Q1 2015. 180 funds tracked by Wall St. Rank hold MNRO as of Q2 2026.
- Royce & Associates reported no remaining Monro position as of Q2 2026 after selling out during the quarter.
- Royce & Associates sold 23,584 Monro shares in Q2 2026, an estimated $378K.
- Royce & Associates first reported a position in Monro in Q2 2013 and held it in 39 quarters.
- Royce & Associates's Monro position peaked at $57.1M in Q1 2015.
- 180 funds tracked by Wall St. Rank held Monro as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.